POSITRON CORP COM USD0.01(POST REV SPLT) (POSC)

0.02
0.00 (0.00)
OTC
Prev Close 0.02
Open 0.02
Day Low/High 0.02 / 0.02
52 Wk Low/High 0.01 / 0.05
Volume 225.00
Exchange OTC
Shares Outstanding 14.28B
Market Cap 285.50K
Div & Yield N.A. (N.A)

Latest News

Positron CEO Issues Letter To Shareholders

Positron Corporation (OTCBB:POSC), a leading molecular imaging company specializing in the field of nuclear cardiology, today issued an update to its shareholders recapping recent activities and highlights.

Positron Awarded $38 Million Of Midwestern Disaster Area Bonds

Positron Corporation (OTCBB:POSC) (“Positron”), Positron Corporation a leading molecular imaging company specializing in the field of nuclear cardiology, announced today that the Indiana Finance Authority (IFA) ...

Positron To Exhibit At The American Society Of Nuclear Cardiology 16th Annual Scientific Session

Positron Corporation (OTCBB:POSC), a leading molecular imaging company specializing in the field of nuclear cardiology, will be exhibiting at the 16th Annual Scientific Session of the American Society of Nuclear ...

City Of Noblesville, Indiana, Passes Global Resolution On Positron Incentive Package

Positron Corporation (OTCBB:POSC) (“Positron”, or the “Company”), a leading molecular imaging company specializing in the field of nuclear cardiology, announced today that in a meeting last night, the...

Positron Executes Memorandum Of Understanding With City Of Noblesville, Indiana; Economic Incentives For Development

Positron Corporation (OTCBB:POSC) (“Positron”, or the “Company”), a leading molecular imaging company specializing in the field of nuclear cardiology, is pleased to announce that it has executed a...

Positron’s CEO Provides Update To Shareholders

Positron Corporation (OTCBB:POSC), a leading molecular imaging company specializing in the field of nuclear cardiology, today provided an update to its shareholders recapping recent developments and their expected...

Positron Seeks International Exposure With Exhibition At European Society Of Cardiology International Conference

Positron Corporation (OTCBB:POSC), a leading molecular imaging company specializing in the field of nuclear cardiology, announced it will be exhibiting at the European Society of Cardiology’s (ESC) International ...

Positron’s PosiRx System Readies For Commercial Deployment

Positron Corporation (OTCBB: POSC) is pleased to announce that its PosiRx system has met critical test standards and guidelines necessary to move on to the commercial deployment stage of its development.

Positron To Launch Automated Radiopharmaceutical System

Positron Corporation (OTCBB:POSC), a leading molecular imaging company specializing in the field of nuclear cardiology, announced the introduction of its automated radiopharmaceutical system, under the name ...

Positron To Launch Indium Oxine As Initial Product Manufactured At Crown Point Facility

Positron Corporation (OTCBB: POSC) a molecular imaging company announced today that it is developing indium oxine, a radiopharmaceutical widely used for the radiolabeling of blood elements.

Positron Retains Investor Relations Firm

Positron Corporation (OTCBB:POSC), a leading molecular imaging company specializing in the field of nuclear cardiology, announced today the appointment of a professional investor relations team, the CSIR Group.

Nuclear Regulatory Commission Approves Radioactive Materials License For Positron Facility

Positron Corporation (OTC BB:POSC) a molecular imaging company focused on nuclear cardiology, announced today that the Nuclear Regulatory Commission (NRC) has approved an amendment to their existing Indiana license for...

Positron’s Attrius® PET Scanner Seeks Market Expansion Into Neurologic Imaging

Positron Corporation (OTCBB:POSC) a molecular imaging solutions company focused on nuclear cardiology, announced today that with the conditional U.

Positron CEO Issues Letter To Shareholders

Positron Corporation (OTCBB:POSC), a leading molecular imaging company specializing in the field of nuclear cardiology, today issued a shareholders letter, which will be posted to its website.

Positron Receives Two Patents For Quantum Photodectors

Positron Corporation (OTCBB:POSC), a leading molecular imaging company specializing in the field of nuclear cardiology, today announced it has received two U.

Positron Receives Highest Mark Of Compliance From Nuclear Regulatory Commission

Positron Corporation (OTCBB:POSC), a leading molecular imaging company specializing in the field of nuclear cardiology, today announced it had achieved the highest mark of compliance in a recent inspection by the ...

PlanClear Releases In-Depth Study On Positron; 2010 Progress And Strong Market Position Cited

Positron Corporation (OTCBB:POSC), a leading molecular imaging company specializing in the field of nuclear cardiology, today announced the release of a report by PlanClear which studied Positron’s 2010 ...

Positron To Exhibit At Radiological Society Of North America's Annual Conference

Conference Hosts Largest, Most Prestigious Radiological Forum Worldwide

Positron Announces Third Quarter 2010 Financial Results

Revenue Increased by Over 400%; Debt Levels Reduced by 90%

Positron Announces Completion Of Cardio-Assist™; Set For Early 2011 Deployment

Positron Corporation (OTCBB:POSC), a leading molecular imaging company specializing in the field of nuclear cardiology, announced today it has completed development of its proprietary automated compounding and unit ...

Positron CEO Discusses Recent Developments, Milestones Ahead

Anticipating Strong Growth Acceleration Through 2012

Positron Opens State-of-the-Art Training Center

Center to Increase Awareness of Positron's Cardiac PET; Only PET Scanner on the Market Optimized Specifically for Cardiac Use